LLY

1,084.65

+0.71%↑

JNJ

208.24

+0.36%↑

ABBV

230.83

+0.29%↑

UNH

329.56

-0.61%↓

AZN

92.71

-0.19%↓

LLY

1,084.65

+0.71%↑

JNJ

208.24

+0.36%↑

ABBV

230.83

+0.29%↑

UNH

329.56

-0.61%↓

AZN

92.71

-0.19%↓

LLY

1,084.65

+0.71%↑

JNJ

208.24

+0.36%↑

ABBV

230.83

+0.29%↑

UNH

329.56

-0.61%↓

AZN

92.71

-0.19%↓

LLY

1,084.65

+0.71%↑

JNJ

208.24

+0.36%↑

ABBV

230.83

+0.29%↑

UNH

329.56

-0.61%↓

AZN

92.71

-0.19%↓

LLY

1,084.65

+0.71%↑

JNJ

208.24

+0.36%↑

ABBV

230.83

+0.29%↑

UNH

329.56

-0.61%↓

AZN

92.71

-0.19%↓

Начало・Списък с акции・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Отворен

1.23 2.5

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.2

Максимум

1.24

Ключови измерители
By Trading Economics
Приходи	17M -26M
EPS	-0.43
Марж на печалбата	-2,190.837
Служители	171
EBITDA	19M -23M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+147.93% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-26M 76M
Предишно отваряне	-1.27
Предишно затваряне	1.23

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

1.43 / 1.6 Подкрепа & съпротива

Pliant Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.12.2025 г., 21:41 ч. UTC

Придобивния, сливания и поглъщания

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

28.12.2025 г., 23:57 ч. UTC

Печалби

'Avatar: Fire and Ash' Tops Domestic Box Office Again -- Barrons.com

28.12.2025 г., 23:48 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

28.12.2025 г., 23:48 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

28.12.2025 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen -- Market Talk

28.12.2025 г., 10:30 ч. UTC

Придобивния, сливания и поглъщания

There's No Happy Ending for Movie Theaters, No Matter Who Wins Warner -- Heard on the Street -- WSJ

26.12.2025 г., 20:22 ч. UTC

Пазарно говорене

Oil Loses Ground On Russia-Ukraine Peace Efforts -- Market Talk

26.12.2025 г., 20:13 ч. UTC

Пазарно говорене

U.S. Natural Gas Gains on Colder Weather Outlook -- Market Talk

26.12.2025 г., 19:24 ч. UTC

Придобивния, сливания и поглъщания

Nvidia's Groq Deal Is an Instagram Moment -- With 1 Big Risk -- Barrons.com

26.12.2025 г., 17:45 ч. UTC

Пазарно говорене

U.S. Diesel Down on Lower Crude Prices, Freight-Sector Lull -- Market Talk

26.12.2025 г., 15:52 ч. UTC

Пазарно говорене

Oil Futures Turn Lower After Steady Start -- Market Talk

26.12.2025 г., 14:58 ч. UTC

Пазарно говорене

Silver, Gold Reach New Highs Amid Geopolitical Tension -- Market Talk

26.12.2025 г., 14:41 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Look to End Week Higher -- Market Talk

26.12.2025 г., 14:28 ч. UTC

Пазарно говорене

Dollar Indexes Flat as Yen Rally Wanes -- Market Talk

26.12.2025 г., 13:47 ч. UTC

Пазарно говорене

Oil Futures Steady in Thin Holiday Trade -- Market Talk

26.12.2025 г., 07:22 ч. UTC

Пазарно говорене

Comex Gold Futures' Strong Bullish Momentum in Play, Chart Shows -- Market Talk

26.12.2025 г., 05:03 ч. UTC

Пазарно говорене

Malaysian Ringgit Likely to Face Pressure From Dollar Strength in 1Q -- Market Talk

26.12.2025 г., 03:38 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

26.12.2025 г., 03:38 ч. UTC

Пазарно говорене

Korean Won Strengthens, Supported by Verbal Interventions -- Market Talk

26.12.2025 г., 02:44 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

26.12.2025 г., 02:44 ч. UTC

Пазарно говорене

Singapore Dollar Weakens Slightly on Likely Position Adjustments -- Market Talk

26.12.2025 г., 01:39 ч. UTC

Пазарно говорене

China's Central Bank Signals Possibility of Easing Policy in Coming Months -- Market Talk

26.12.2025 г., 01:14 ч. UTC

Пазарно говорене

Oil Edges Higher Amid Geopolitical Tensions -- Market Talk

26.12.2025 г., 00:34 ч. UTC

Пазарно говорене

Yen Mostly Weakens Amid Risk-on Sentiment -- Market Talk

26.12.2025 г., 00:15 ч. UTC

Пазарно говорене

Nikkei Gains 0.6%, Led by Tech, Videogame Stocks -- Market Talk

25.12.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25.12.2025 г., 23:40 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25.12.2025 г., 00:20 ч. UTC

Придобивния, сливания и поглъщания

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24.12.2025 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24.12.2025 г., 21:26 ч. UTC

Придобивния, сливания и поглъщания

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

Сравнение с други в отрасъла

Ценова промяна

Pliant Therapeutics Inc Прогноза

Ценова цел

By TipRanks

147.93% нагоре

12-месечна прогноза

Среден 3 USD 147.93%

Висок 4 USD

Нисък 2 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Pliant Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

4 ratings

Купи

Задържане

Продай

Според 4 анализатори, дали борсови рейтинги на Pliant Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

1.43 / 1.6Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.